AnaptysBio will end the development of its experimental drug to treat eczema as the treatment failed to meet the goals of a ...

Nara Smith shared pictures of her recent eczema flare-ups on Instagram, where the model got candid about her journey with the ...

Nara Smith shared images and a lengthy caption detailing the health challenges she's experienced in the three years since her ...

The misconception of eczema being contagious likely arises from its association with other infections that can occur among ...

AnaptysBio, Inc. (NASDAQ:ANAB) announced that investigational ANB032, a BTLA agonist, did not meet the primary and secondary ...

Eczema-prone skin needn't mean a mundane moisturiser; our edit includes the ingredient-led, the fragranced and the luxurious ...

Being a social media star may seem like the high life but Nara Smith, fashion model-turned-TikTok creator just pulled back the curtain on all that appears glitz and glam by getting candid about her ...

Shares of AnaptysBio Inc. remained flat in premarket trading Thursday after plunging over 32% in the prior session, marking ...

Chronic exposure to irritants, allergens, and repetitive hand washing are established risk factors for chronic hand eczema.

Q32 Bio still sees potential for its anti-IL-7R antibody as an alopecia treatment despite failing a phase 2 eczema study—but ...

It's still early science -- studies in mice and in human cells -- but researchers are on the trail of an effective n ...